Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Carcinoma × Aspirin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Venous Thromboembolism 1 Polycythemia Vera 1 Pancreatic Neoplasms 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lynch syndrome I (site-specific colonic cancer) 1 Liver Cirrhosis 1 Fibrosis 1 Endometrial Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1

Interventions

Specimen Handling 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Magnetic Resonance Spectroscopy 2 Cetuximab 2 selinexor 1 ponatinib 1 poly ICLC 1 pemigatinib 1 neratinib 1 fludarabine phosphate 1 fludarabine 1 donafenib 1 cobimetinib 1 ceritinib 1 cemiplimab 1 brigatinib 1 abemaciclib 1 Thymopentin 1 Taxes 1 Surgical Procedures, Operative 1 Standard of Care 1 Radiosurgery 1 Radiation 1 Paclitaxel 1 Oxaliplatin 1 Nivolumab 1 Neck Dissection 1 NF protocol 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07529262 2026-04-14

AspiRe HCC

Curtin University

Phase 3 Not yet recruiting

Carcinoma, Fibrosis, Liver Cirrhosis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡